Zeo ScientifiX, Inc. (ZEOX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3321 COLLEGE AVENUE DAVIE, FL 33314 |
| State of Incorp. | NV |
| Fiscal Year End | October 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 1/31/2026 MRQ | 10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 221 | 657 | 1,756 | 3,753 | 109 | 591 | |||
| Cash and cash equivalent | 221 | 657 | 1,756 | 3,753 | 109 | 591 | |||
| Receivables | 35 | 197 | 30 | 191 | 104 | 29 | |||
| Inventory, net of allowances, customer advances and progress billings | 423 | 232 | 310 | 249 | 235 | 147 | |||
| Inventory | 423 | 232 | 310 | 249 | 235 | 147 | |||
| Prepaid expense | 279 | 79 | 106 | 173 | 70 | 79 | |||
| Total current assets: | 958 | 1,165 | 2,202 | 4,366 | 517 | 846 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 105 | ||||||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 569 | 478 | 573 | 1,684 | 1,113 | 365 | |||
| Other undisclosed noncurrent assets | 7 | 151 | 302 | 18 | |||||
| Total noncurrent assets: | 569 | 478 | 580 | 1,834 | 1,416 | 488 | |||
| TOTAL ASSETS: | 1,527 | 1,643 | 2,782 | 6,201 | 1,933 | 1,334 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,980 | 1,719 | 2,612 | 2,379 | 1,873 | 766 | |||
| Accrued liabilities | 889 | 786 | 748 | 758 | 1,542 | 1,156 | |||
| Other undisclosed accounts payable and accrued liabilities | 1,091 | 933 | 1,864 | 1,621 | 331 | (391) | |||
| Debt | 276 | 685 | 680 | 144 | 140 | 233 | |||
| Disposal group, including discontinued operation | 126 | 126 | |||||||
| Due to related parties | ✕ | ✕ | ✕ | ✕ | 221 | 221 | 221 | ||
| Other undisclosed current liabilities | 617 | 884 | 718 | 1,320 | 1,766 | 1,194 | |||
| Total current liabilities: | 2,873 | 3,288 | 4,010 | 4,063 | 4,126 | 2,540 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 13 | 220 | 332 | 186 | |||||
| Long-term debt, excluding current maturities | 332 | ||||||||
| Finance lease, liability | 13 | 220 | 119 | ||||||
| Liabilities, other than long-term debt | 29 | ||||||||
| Operating lease, liability | 29 | 67 | |||||||
| Other undisclosed noncurrent liabilities | 77 | 8 | 140 | (67) | |||||
| Total noncurrent liabilities: | 77 | 8 | 13 | 249 | 472 | 186 | |||
| Total liabilities: | 2,950 | 3,296 | 4,023 | 4,312 | 4,599 | 2,726 | |||
| Equity | |||||||||
| Equity, attributable to parent | (1,423) | (1,653) | (1,241) | 1,889 | (2,666) | (1,392) | |||
| Common stock | 7 | 6 | 7 | 1,479 | 1,132 | 940 | |||
| Additional paid in capital | 66,304 | 60,554 | 56,260 | 50,931 | 37,827 | 26,536 | |||
| Accumulated deficit | (67,734) | (62,213) | (57,508) | (50,521) | (41,625) | (28,868) | |||
| Total equity: | (1,423) | (1,653) | (1,241) | 1,889 | (2,666) | (1,392) | |||
| TOTAL LIABILITIES AND EQUITY: | 1,527 | 1,643 | 2,782 | 6,201 | 1,933 | 1,334 | |||
Income Statement (P&L) ($ in thousands)
| 1/31/2026 TTM | 10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 5,199 | 4,620 | 4,558 | 6,491 | 5,597 | 3,056 | ||
| Cost of revenue | (931) | (844) | (508) | (754) | (548) | (399) | ||
| Cost of product and service sold | (931) | (37) | ||||||
| Gross profit: | 4,268 | 3,776 | 4,051 | 5,737 | 5,050 | 2,657 | ||
| Operating expenses | (9,654) | (9,095) | (10,818) | (14,580) | (17,794) | (15,095) | ||
| Operating loss: | (5,386) | (5,319) | (6,767) | (8,843) | (12,744) | (12,438) | ||
| Nonoperating income (expense) | (136) | 751 | (10) | 250 | 25 | 33 | ||
| Other nonoperating income (expense) | 101 | (10) | 250 | 25 | 33 | |||
| Interest and debt expense | (431) | (398) | (178) | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (5,522) | (4,568) | (7,208) | (8,992) | (12,719) | (12,583) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 95 | (38) | 0 | |||||
| Loss from continuing operations before income taxes: | (5,522) | (4,568) | (7,208) | (8,897) | (12,757) | (12,583) | ||
| Income tax benefit | 349 | 217 | 3,215 | 3,168 | ||||
| Other undisclosed income from continuing operations | ||||||||
| Loss from continuing operations: | (5,173) | (4,351) | (7,208) | (8,897) | (9,541) | (9,415) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | (9,541) | (9,415) | |
| Other undisclosed net loss | (348) | (354) | (3,215) | (3,168) | ||||
| Net loss: | (5,521) | (4,705) | (7,208) | (8,897) | (12,757) | (12,583) | ||
| Other undisclosed net income attributable to parent | 222 | |||||||
| Net loss available to common stockholders, diluted: | (5,521) | (4,705) | (6,987) | (8,897) | (12,757) | (12,583) | ||
Comprehensive Income ($ in thousands)
| 1/31/2026 TTM | 10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (5,521) | (4,705) | (7,208) | (8,897) | (12,757) | (12,583) | ||
| Comprehensive loss, net of tax, attributable to parent: | (5,521) | (4,705) | (7,208) | (8,897) | (12,757) | (12,583) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.